Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 11, 2023

SELL
$0.36 - $0.63 $459 - $803
-1,275 Reduced 7.35%
16,065 $6,000
Q4 2022

Feb 07, 2023

SELL
$0.41 - $18.6 $4,715 - $213,900
-11,500 Reduced 39.88%
17,340 $8,000
Q3 2022

Nov 14, 2022

BUY
$0.57 - $34.65 $5,984 - $363,825
10,500 Added 57.25%
28,840 $24,000
Q1 2022

May 04, 2022

BUY
$1.16 - $2.5 $21,274 - $45,850
18,340 New
18,340 $24,000
Q1 2020

May 11, 2020

SELL
$1.15 - $3.29 $19,881 - $56,877
-17,288 Closed
0 $0
Q4 2019

Feb 05, 2020

BUY
$0.84 - $1.2 $14,521 - $20,745
17,288 New
17,288 $20,000

Others Institutions Holding PAVM

# of Institutions
1
Shares Held
2.24M
Call Options Held
0
Put Options Held
0

About PAVmed Inc.


  • Ticker PAVM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 90,999,104
  • Market Cap $93.7M
  • Description
  • PAVmed Inc. operates as a medical device company in the United States. The company's lead products include CarpX, a percutaneous device to treat carpal tunnel syndrome; and EsoCheck, an esophageal cell collection device for the early detection of adenocarcinoma of the esophagus and Barrett's Esophagus (BE); and EsoGuard, a bisulfite-converted ne...
More about PAVM
Track This Portfolio

Track Commonwealth Equity Services, LLC Portfolio

Follow Commonwealth Equity Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Commonwealth Equity Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Commonwealth Equity Services, LLC with notifications on news.